Literature DB >> 15223685

Expanding hepatocytes in vitro before cell transplantation: donor age-dependent proliferative capacity of cultured human hepatocytes.

J Walldorf1, H Aurich, H Cai, D Runge, B Christ, S C Strom, W E Fleig.   

Abstract

BACKGROUND: For hepatocyte transplantation as well as experimental purposes, it would be advantageous to be able to expand human hepatocytes in vitro. However, under serum-free conditions, even with supplements of HGF (hepatic growth factor) and EGF (epidermal growth factor), proliferation of human hepatocytes is hampered. The aim of this study was to identify differences in the proliferative capacity of cultured primary human hepatocytes related to the age of the liver donors.
METHODS: Proliferation was determined by BrdU-uptake, ploidy was measured using propidium iodide staining and flow cytometry, and the expression of cell cycle related proteins was determined by Western blotting.
RESULTS: During the initial culture, juvenile hepatocytes proliferated better than adult hepatocytes. The proliferation rate declined to barely detectable levels after 8 days in culture in both juvenile and adult hepatocytes. The higher proliferative capacity of juvenile hepatocytes was associated with a larger fraction of diploid cells and a higher viability. The expression of regulatory cell cycle related proteins was higher in juvenile than in adult hepatocytes.
CONCLUSIONS: The proliferation of human hepatocytes in vitro is critically related to a large fraction of diploid hepatocytes. The expression of regulatory cell cycle proteins reflects the proliferative capacity of cultured human hepatocytes. Juvenile as compared to adult human hepatocytes may be better suited for expansion in culture and could have a stronger repopulation capacity in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223685     DOI: 10.1080/00365520410005586

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.

Authors:  Sylvie Goulinet-Mainot; Hadrien Tranchart; Marie-Thérèse Groyer-Picard; Panagiotis Lainas; Papa Saloum Diop; Delphine Holopherne; Patrick Gonin; Karim Benihoud; Nathalie Ba; Olivier Gauthier; Dominique Franco; Catherine Guettier; Danièle Pariente; Anne Weber; Ibrahim Dagher; Tuan Huy Nguyen
Journal:  Cell Med       Date:  2012-05-08

2.  Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.

Authors:  Ines Aurich; Lutz P Mueller; Hendryk Aurich; Jana Luetzkendorf; Kai Tisljar; Matthias M Dollinger; Wiebke Schormann; Jens Walldorf; Jan G Hengstler; Wolfgang E Fleig; Bruno Christ
Journal:  Gut       Date:  2006-08-23       Impact factor: 23.059

3.  Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients.

Authors:  Christian Hendrich; Engelmaier Franz; Gerhart Waertel; Rolf Krebs; Marcus Jäger
Journal:  Orthop Rev (Pavia)       Date:  2009-10-10

Review 4.  A review of cellularization strategies for tissue engineering of whole organs.

Authors:  Michelle E Scarritt; Nicholas C Pashos; Bruce A Bunnell
Journal:  Front Bioeng Biotechnol       Date:  2015-03-30

5.  Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes.

Authors:  Takeshi Katsuda; Juntaro Matsuzaki; Tomoko Yamaguchi; Yasuhiro Yamada; Marta Prieto-Vila; Kazunori Hosaka; Atsuko Takeuchi; Yoshimasa Saito; Takahiro Ochiya
Journal:  Elife       Date:  2019-08-08       Impact factor: 8.713

Review 6.  Hepatocyte organoids and cell transplantation: What the future holds.

Authors:  Weng Chuan Peng; Lianne J Kraaier; Thomas A Kluiver
Journal:  Exp Mol Med       Date:  2021-10-18       Impact factor: 8.718

7.  Injury-dependent retention of intraportally administered mesenchymal stromal cells following partial hepatectomy of steatotic liver does not lead to improved liver recovery.

Authors:  Nele Boeykens; Peter Ponsaerts; Annemie Van der Linden; Zwi Berneman; Dirk Ysebaert; Kathleen De Greef
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.